This heterogeneity in clinical behaviour might be related to the high genetic variability described in angiosarcomas, with several genes abnormalities identified in B-AS patients such as CIC, PLCG1, KDR and MYC (14–15). The gene discussed is MYC; the disease is angiosarcoma.